SEARCH
Hope for long Covid sufferers as new study will trial Pfizer's antiviral Paxlovid in patients - 1br
1BN-RADIO
2022-11-25
Views
2
Description
Share / Embed
Download This Video
Report
Paxlovid, the pharma giant's flagship Covid drug, gained emergency approval in the US last December to treat high-risk patients - slashing their risk of death by 90 per cent.
VIEW MORE : https://bit.ly/1breakingnews
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x8ftx74" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:03
La EMA aprueba 'Paxlovid', el antiviral de Pfizer contra el coronavirus
00:35
Pfizer busca la aprobación de la FDA de su medicamento antiviral oral Covid, Paxlovid
00:35
Pfizer busca la aprobación de la FDA de su medicamento antiviral oral Covid-19, Paxlovid.
00:38
Pfizer Sets Price for Covid Antiviral Drug Paxlovid at a Staggering $1,390 for Commercial Release
03:02
The antiviral Covid-19 pill Paxlovid by Pfizer is effective against coronavirus
00:35
Pfizer busca la aprobación de la FDA de su medicamento antiviral oral Covid-19, #Paxlovid.
02:57
Pfizer vaccine: Pfizer vaccine लगने के बाद भी लोग हुए Corona Positive | Pfizer's Covid-19 vaccine
01:05
Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament
00:21
New COVID pill: EMA gives Pfizer's antiviral drug Paxlovid the green light to be used in the EU
02:24
US authorises Pfizer oral Covid-19 pill Paxlovid for home treatment
01:34
Cofepris autoriza para uso de emergencia el tratamiento paxlovid de Pfizer
03:55
This week in COVID: Moderna sues Pfizer-BioNTech, Paxlovid study shows no benefit for certain - 1br